Because of the potential utility of a cell permeable Enolase inhibitor for molecular targeted therapy of ENO1-deleted tumors, we systematically evaluated ENOblock as an inhibitor of Enolase in vitro and for selective killing of ENO1-deleted cancer cells. This evidence concerns the gene ENO1 and cancer.